Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PRFX | US
-0.08
-3.51%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
24/03/2026
2.20
2.23
2.25
2.16
PainReform Ltd. a clinical stage specialty pharmaceutical company engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110 a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv Israel.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
64.8%1 month
74.5%3 months
121.1%6 months
101.4%-
-
0.63
-0.03
0.02
-2.32
-
-
-17.81M
4.90M
4.90M
-
-
-
-
-716.67
0.07
2.65
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.87
Range1M
1.36
Range3M
3.13
Rel. volume
0.52
Price X volume
36.30K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| China SXT Pharmaceuticals Inc | SXTC | Drug Manufacturers-Specialty & Generic | 1.41 | 4.90M | -4.08% | n/a | 19.00% |
| Biofrontera Inc. Common Stock | BFRI | Drug Manufacturers-Specialty & Generic | 0.811 | 4.50M | -4.40% | n/a | 13.20% |
| Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 2.34 | 3.13M | -8.24% | n/a | 8.44% |
| SHPH | SHPH | Drug Manufacturers-Specialty & Generic | 0.9382 | 2.76M | 5.89% | n/a | 144.16% |
| Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 0.802 | 2.29M | -3.96% | n/a | -104.44% |
| Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 0.15 | 1.84M | 1.00 | 27.85% | |
| Imc Mortgage Co | IMCC | Drug Manufacturers-Specialty & Generic | 0.5996 | 1.36M | -7.30% | n/a | 222.75% |
| Premier Biomedical Inc | BIEI | Drug Manufacturers-Specialty & Generic | 0.0004 | 439.55K | n/a | -22.64% | |
| Bio-Path Holdings Inc | BPTH | Drug Manufacturers-Specialty & Generic | 0.057 | 145.47K | n/a | 4.26% | |
| PETROS PHARMACEUTICALS INC | PTPI | Drug Manufacturers-Specialty & Generic | 0.0072 | 69.17K | 0.00% | n/a | 83.11% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.345 | 3.28M | -6.12% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.055 | 1.13M | -3.52% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.007 | 645.50K | 0.00% | n/a | -37.05% |
| Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 12.8 | 0 | 0.27% | n/a |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.32 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.63 | 13.15 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 121.07 | - | Riskier |
| Debt to Equity | -0.03 | -1.88 | Expensive |
| Debt to Assets | 0.02 | 0.48 | Cheaper |
| Market Cap | 4.90M | - | Emerging |